Reven Pharmaceuticals
Reven Pharmaceuticals, based in Westminster, CO, is a cutting-edge biopharmaceutical company focused on developing innovative pharmacological solutions that target the root cause of diseases by restoring immune system homeostasis. Their flagship product, RJX, is a stand-alone drug formulated to impact various disease indications stemming from inflammation, from cancer to cardiovascular disease.
Founded by co-founder and CSO Michael Volk, Reven Pharmaceuticals aims to revolutionize the healthcare industry by introducing a new generation of medications that address unmet medical needs and improve patient outcomes. With a strong emphasis on social accountability and technological advancements, Reven is at the forefront of driving advancements in the hypoxia market and beyond.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.